Nitric oxide (NO), a low molecular weight signaling molecule, plays critical roles in both cellular health and disease. There is continued interest in new modalities for the controlled therapeutic delivery of NO to cells and tissues. The physicochemical properties of NO (including its short half-life and on-demand synthesis at the point of function), however, pose considerable challenges for its specific and efficient delivery. Recently, a number of nanoparticle (NP)-based systems are described that address some of these issues by taking advantage of the unique attributes of the NP carrier to effect efficient NO delivery. This review highlights the progress that has been made over the past 5 years in the use of various constructs for the therapeutic delivery of NO.
Keywords: bioconjugate; drug delivery; liposome; nanoparticle; nitric oxide.
This review details progress made over the past 5 years in the implementation of various nanoparticle (NP) bioconjugates for the therapeutic delivery of nitric oxide. Various NP formulations including liposomes, polymeric NPs, and hard NPs such as AuNPs and upconversion NPs are covered and we discuss the inherent advantages and challenges in using these materials for the controlled delivery of nitric oxide to cells and tissues.